Abstract:SQ109 is an antitubercular drug candidate that has recently also displayed broad‐spectrum antiparasitic activity. Following an inverse strategy, the antiparasitic N,N′‐disubstituted diamines were repurposed as antimycobacterial drug candidates. Several compounds displayed activity against M. tuberculosis H37Rv and M. avium with MICs below 10 μM, with compound 3c standing out as the best candidate. In previous studies, we demonstrated the potent activity of a library of 25 N,N′‐disubstituted diamines (NNDDA) toward Trypanosomatid and Apicomplexa parasites. Considering the structure similarity between this collection and SQ109, an antituberculosis compound, and its compelling antiparasitic properties, we aimed to repurpose this library for tuberculosis treatment. We assayed this collection against Mycobacterium tuberculosis H37Rv and M. avium, obtaining several compounds with MIC values below 10 μM. The most active analogs were also evaluated against M. smegmatis, a non‐pathogenic species, and the non‐tuberculosis mycobacteria M. abscessus, M. kansasii, and M. fortuitum. 3c stands out as the lead mycobacterial compound of the collection, with potent activity against M. tuberculosis (minimal inhibitory concentration [MIC] = 3.4 μM) and moderate activity against M. smegmatis, M. kansasii, and M. fortuitum (all with MIC values of 26.8 μM). To unravel the mechanism of action, we employed the web‐based platform Polypharmacology Browser 2 (PPB2), obtaining carbonic anhydrases as potential drug targets. Nevertheless, none of the compounds displayed experimental inhibition. In summary, our study confirms the validity of the repurposing approach and underscores the antimycobacterial potential of NNDDA compounds, especially the analog 3c, setting a stepping stone for further studies.

Synthesis of Novel [1,2]-Diamines with Antituberculosis Activity

Synthesis, 3D-QSAR Analysis and Biological Evaluation of Quinoxaline 1,4-Di-n-oxide Derivatives As Antituberculosis Agents

Exploration of isoxazole‐carboxylic acid methyl ester based 2‐substituted quinoline derivatives as promising antitubercular agents

Synthesis and Evaluation of (S,S)-N,N '-Bis-[3-(2,2 ',6,6 '-Tetramethylbenzhydryloxy)-2-hydroxy-propyl]-ethylenediamine (S2824) Analogs with Anti-Tuberculosis Activity

Synthesis of novel pleuromutilin derivatives. Part 1: preliminary studies of antituberculosis activity.

Design, Synthesis and Antimycobacterial Activity of Novel Imidazo[1,2-a]pyridine Amide-Cinnamamide Hybrids.

Design, synthesis and antimycobacterial activity of novel nitrobenzamide derivatives

Design and Synthesis of Novel Benzimidazole Derivatives As Anti-Tuberculosis Agents.

Design, synthesis, and biological evaluation of m-amidophenol derivatives as a new class of antitubercular agents.

Repurposing antiparasitic N,N′‐aliphatic diamine derivatives as promising antimycobacterial agents

Design, Synthesis, and Evaluation of the Antitubercular Activity of 5-Phenyl Substituted-5, 6-dihydropyrido[2, 3- d ]pyrimidine-4, 7( 3H , 8H )-dione Compounds

Synthesis of Novel 18Β-Glycyrrhetinic Acid Derivatives Containing Heterocycle Amides and Their Antituberculosis Activities

Design, Synthesis, and Antitubercular Activity of 3‐amidophenols with 5‐heteroatomic Substitutions

Design, synthesis and antimycobacterial activity of 3,5-dinitrobenzamide derivatives containing fused ring moieties.

Design, Synthesis, and Biological Evaluation of Novel Thiazolidinone-Containing Quinoxaline-1,4-di-<i>N</i>-oxides as Antimycobacterial and Antifungal Agents

Design and Synthesis of Novel Triazoloquinazolin-5(3H)-one Analogues as Promising Antitubercular Agents

Synthesis and Evaluation of Anti-Tubercular and Antibacterial Activities of New 4-(2,6-dichlorobenzyloxy)phenyl Thiazole, Oxazole and Imidazole Derivatives. Part 2

Benzylsulfanyl benzo-heterocycle amides and hydrazones as new agents against drug-susceptible and resistant Mycobacterium tuberculosis.

Design, synthesis, anti-tubercular activity, and computational studies of novel 3-(quinolin-3-yl)-1-phenylprop-2-en-1-one derivatives

Design, Synthesis and Antimycobacterial Activity of Less Lipophilic Q203 Derivatives Containing Alkaline Fused Ring Moieties.

Synthesis and Antitubercular Evaluation of Reduced Lipophilic Imidazo[1,2-A]pyridine-3-carboxamide Derivatives